Immunity 2008, 29:319–324.GSK2118436 cost PubMedCrossRef 25. von Specht BU, Knapp B, Muth G, Broker M, Hungerer KD, Diehl KD, Massarrat K, Seemann A, Domdey H: Protection of immunocompromised mice against lethal infection Nirogacestat purchase with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins. Infect Immun 1995, 63:1855–1862.PubMed 26. Zuercher AW, Imboden MA, Jampen S, Bosse D, Ulrich M, Chtioui H, Lauterburg BH, Lang AB: Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine. Clin Exp Immunol 2006, 143:132–138.PubMedCrossRef

27. Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan Stattic cell line C, Schendel DJ, Krauss-Etschmann S: Pulmonary T(H)2 response in Pseudomonas aeruginosa -infected patients with cystic fibrosis. J Allergy Clin Immunol 2006, 117:204–211.PubMedCrossRef 28. Rakhimova E, Munder A, Wiehlmann L, Bredenbruch F, Tummler B: Fitness of isogenic colony morphology variants of Pseudomonas aeruginosa in murine airway infection. PLoS ONE 2008, 3:e1685.PubMedCrossRef 29. Oliver A, Canton R, Campo P, Baquero F, Blazquez J: High frequency of hypermutable

Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251–1254.PubMedCrossRef 30. Govan JR, Harris GS: Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci 1986, 3:302–308.PubMed 31. Pier GB, Meluleni G, Goldberg JB: Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies. Infect Immun 1995, 63:2818–2825.PubMed 32. Belkaid Y: Regulatory T cells and infection: a dangerous necessity. Nat

Rev Immunol 2007, 7:875–888.PubMedCrossRef 33. Ueno K, Koga T, Kato K, Golenbock DT, Gendler SJ, Kai H, Kim KC: MUC1 mucin is a negative regulator of toll-like receptor signaling. Am J Respir Cell Mol Biol 2008, 38:263–268.PubMedCrossRef 34. Machen TE: Innate immune response Dapagliflozin in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol 2006, 291:C218–230.PubMedCrossRef 35. Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM: Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa . Am J Physiol Lung Cell Mol Physiol 2007, 292:L312–322.PubMedCrossRef 36. De Luca A, Montagnoli C, Zelante T, Bonifazi P, Bozza S, Moretti S, D’Angelo C, Vacca C, Boon L, Bistoni F, Puccetti P, Fallarino F, Romani L: Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007, 179:5999–6008.PubMed 37. Rawling EG, Martin NL, Hancock REW: Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF. Infect Immun 1995, 63:38–42.PubMed 38.